Archives of Physical Medicine and Rehabilitation
Volume 88, Issue 5 , Pages 551-554 , May 2007

Brain Injury Research: Lessons for Reinventing the Future. The 38th Zeiter Lecture

Presented in part to the Interagency Conference on Traumatic Brain Injury, March 11, 2006, Bethesda, MD; and to the American Academy of Physical Medicine and Rehabilitation, November 9, 2006, Honolulu, HI. The lecture is based in part from: Zafonte RD. Update on biotechnology for TBI rehabilitation. J Head Trauma Rehabil 2006;21:403-7.

  • Ross D. Zafonte, DO

      Affiliations

    • Corresponding Author InformationCorrespondence to Ross D. Zafonte, DO, University of Pittsburgh, UPMC Health System, 3471 Fifth Ave, Ste 201, Pittsburgh, PA 15215

References 

  1. Floel A, Cohen L. Translational studies in neurorehabilitation: from bench to bedside. Cog Behav Neurol. 2006;19:1–10
  2. Faden AI. Neuroprotection and traumatic brain injury: theoretical option or realistic proposition. Curr Opion Neurol. 2002;15:707–712
  3. Bullock MR, Lyeth BG, Muizelaar JP. Current status of neuroprotection trials for traumatic brain injury: lessons from animal models and clinical studies. Neurosurgery. 1999;45:207–217discussion 217-20
  4. Muizelaar JP, Marmarou A, Young HF, et al. Improving the outcome of severe head injury with the oxygen radical scavenger polyethylene glycol-conjugated superoxide dismutase: a phase II trial. J Neurosurg. 1993;78:375–382
  5. Young B, Runge JW, Waxman KS, et al. Effects of peforgotein on neurologic outcome of patients with severe head injury (A multicenter, randomized controlled trial). JAMA. 1996;276:538–543
  6. Edwards P, Arango M, Balica L, et al. CRASH trial collaborators Final results of the MRC CRASH, a randomized placebo controlled trial of intravenous corticosteroids in adults with head injury-outcomes at 6 months. Lancet. 2005;365:1957–1959
  7. Maas AI, Murray G, Henney H, et al. Pharmos TBI investigators Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase III randomised, placebo-controlled, clinical trial. Lancet Neurol. 2006;5:38–45
  8. Clifton GL, Miller ER, Choi SC, et al. Lack of effect on induction of hypothermia after acute brain injury. N Engl J Med. 2001;344:556–563
  9. Marion DW, Penrod LE, Kelsey SF, et al. Treatment of traumatic brain injury with moderate hypothermia. N Engl J Med. 1997;336:540–546
  10. Bullock R, Chesnut RM, Clifton G, et al. Brain Trauma Foundation Guidelines for the management of severe head injury. Chicago: AANS Pr; 1996;
  11. Narayan RK, Michel ME, Ansell B, et al. Clinical trials in head injury. J Neurotrauma. 2002;19:503–557
  12. Wright DW, Kellermann AL, Hertzberg VS, et al. ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury. Ann Emerg Med. 2007;49:391–402
  13. Temkin NR, Dikmen SS, Wilensjy AJ, Keihm J, Chabal S, Winn HR. A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures. N Engl J Med. 1990;323:497–502
  14. Gordon WA, Zafonte R, Cicerone K, et al. Traumatic brain injury rehabilitation: state of the science. Am J Phys Med Rehabil. 2006;85:343–382
  15. Warden DL, Gordon B, Mcallister TW, et al. Neurobehavioral Guidelines Working Group Guidelines for the pharmacologic treatment of neurobehavioral sequelae of traumatic brain injury. J Neurotrauma. 2006;23:1468–1501
  16. Whyte J, Hart M, Vaccaro T, et al. Effects of methylphenidate on attention deficits after traumatic brain injury: a multidimensional, randomized, controlled trial. Am J Phys Med Rehabil. 2004;83:401–420
  17. Zafonte R. Update on biotechnology for TBI rehabilitation. J Head trauma Rehabil. 2006;21:403–407
  18. Wagner A, Fabio A, Puccio A, et al. Gender associations with cerebrospinal fluid glutamate and lactate/pyruvate levels after severe traumatic brain injury. Crit Care Med. 2005;33:407–413
  19. Wagner A, Chen X, Kline A, Li Y, Zafonte R, Dixon C. Gender and environmental enrichment impact dopamine transporter expression after experimental traumatic brain injury. Exp Neurol. 2005;195:475–483
  20. Hayman MW, Smith KH, Cameron NR, Przyborski SA. Growth of human stem cell-derived neurons on solid three-dimensional polymers. J Biochem Biophys Methods. 2005;62:231–240
  21. Longhi L, Watson D, Saatman K, et al. Ex vivo gene therapy using targeted engraftment of NGF expressing human NT2 N neurons attenuates cognitive deficits following traumatic brain injury in mice. J Neurotrauma. 2004;21:1723–1736
  22. Longhi L, Zainer E, Royo N, Stocchetti N, McIntosh T. Stem cell transplantation as a therapeutic strategy for traumatic brain injury. Transpl Immunol. 2005;15:143–148
  23. Kondziolka D, Steinberg GK, Wechsler L, et al. Neurotransplantation for patients with subcortical motor stroke: a phase 2 randomized trial. J Neurosurg. 2005;103:38–45
  24. Brown J, Lutsep H, Weinand M, Cramer S. Motor cortex stimulation for the enhancement of recovery from stroke: a prospective multicenter safety study. Neurosurgery. 2006;58:464–473
  25. Silva GA. Neuroscience nanotechnology: progress, opportunities and challenges. Nat Rev Neurosci. 2006;75:65–74
  26. Brewer B, Fagan M, Klatzky R, Matsuoka T. Perceptual limits for a robotic rehabilitation environment using visual feedback distortion. IEEE Trans Neural Syst Rehabil Eng. 2005;13:1–11
  27. Loeb G, Peck R, Moore W, Hood K. BION system for distributed neural prosthetic interfaces. Med Eng Phys. 2001;23:9–18
  28. Weber D, Stein R, Chan K, et al. Functional electrical stimulation using microstimulators to correct foot drop: a case study. Can J Physiol Pharmacol. 2004;82:784–792
  29. Cooper R, Ding D, Simpson R, et al. Virtual reality and computer enhanced training applied to wheeled mobility: an overview of work in Pittsburgh. Assist Technol. 2005;17:159–170
  30. Dicianno B, Spaeth D, Cooper R, Fitzgerald S, Boninger M. Advancements in power wheelchair joystick technology: effects of isometric joysticks and signal conditioning on driving performance. Am J Phys Med Rehabil. 2006;85:631–639
  31. Ochoa J, Makarenkova V, Bansal V. A rational use of immune enhancing diets: when should we use dietary arginine supplements?. Nutr Clin Pract. 2004;19:216–225
  32. Millbrandt E, Kersten A, Kong L, et al. Haloperidol is associated with lower hospital mortality in mechanically ventilated patients. Crit Care Med. 2005;33:226–229
  33. Zafonte R, Dixon C, Kline A. Chronic risperidone treatment after experimental traumatic brain injury negatively impacts functional outcome. [abstract] Arch Phys Med Rehabil. 2005;86(9):E9

 Supported by the National Institute on Disability and Rehabilitation Research (grant no. H133P70013-00) and the National Institutes of Health (grant no. 1UO1HD42678-02).

 No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit upon the author(s) or upon any organization with which the author(s) is/are associated.

PII: S0003-9993(07)00176-1

doi: 10.1016/j.apmr.2007.02.039

Archives of Physical Medicine and Rehabilitation
Volume 88, Issue 5 , Pages 551-554 , May 2007

Article Tools